Literature DB >> 26065031

MicroRNAs Inducing Proliferation of Quiescent Adult Cardiomyocytes.

Raghav Pandey1, Rafeeq P H Ahmed2.   

Abstract

In the United States, each year over 700,000 people suffer from a heart attack and over 25% of deaths are related to heart disease, making it the leading cause of death. Following ischemic injury a part of the heart muscle is replaced by a scar tissue, reducing its functioning capacity. Recent advancements in surgical intervention and pharmacotherapy only provide symptomatic relief and do not address the root cause of the problem which is the massive loss of cardiomyocytes (CM). Therefore, the development of novel therapeutic intervention for the repair and regeneration of ischemic myocardium remains an area of intense research. While existing CM in zebra fish and neonatal mice are known to proliferate and replenish the infarcted heart, it has been shown that adult mammalian CM lose this ability, thus preventing regeneration of the scar tissue. There have been many attempts to facilitate regeneration of ischemic heart but have met with limited success. Micro-RNAs (miRNAs) are one of the promising candidates towards this goal as they are known to play important regulatory roles during differentiation and tissue regeneration, and regulate genetic information by post-transcriptional modification as well as regulation of other miRNAs. While previous work by Eulalio et al., showed miRNAs inducing proliferation in neonatal CM (NCM), we here identify miRNAs inducing proliferation of rat adult-CM (ACM). This commentary while analyses recent work by Eulalio et al[1] also shows some new data with microRNAs in rat adult-CMs. Further work into the mechanism of these miRNAs can determine their therapeutic potential towards regenerating cardiac tissue post ischemic injury.

Entities:  

Keywords:  Adult Cardiomyocytes; Cardiomyocytes; Cardiovascular Diseases; MicroRNA; Myocardial Infarction

Year:  2015        PMID: 26065031      PMCID: PMC4459736          DOI: 10.14800/crm.519

Source DB:  PubMed          Journal:  Cardiovasc Regen Med        ISSN: 2378-3141


  39 in total

Review 1.  Stem celltherapy for ischemic heart failure.

Authors:  Doreen Rosenstrauch; Gregor Poglajen; Nina Zidar; Igor D Gregoric
Journal:  Tex Heart Inst J       Date:  2005

Review 2.  Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants.

Authors:  Jr-Shiuan Yang; Eric C Lai
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

Review 3.  Insight to the pathophysiology of stable angina pectoris.

Authors:  Dimitris Tousoulis; Emmanuel Androulakis; Anna Kontogeorgou; Nikolaos Papageorgiou; Marietta Charakida; Katerina Siama; George Latsios; Gerasimos Siasos; Anna-Maria Kampoli; Panagiotis Tourikis; Kostas Tsioufis; Christodoulos Stefanadis
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

4.  Cyclin A2 induces cardiac regeneration after myocardial infarction through cytokinesis of adult cardiomyocytes.

Authors:  Scott D Shapiro; Amaresh K Ranjan; Yoshiaki Kawase; Richard K Cheng; Rina J Kara; Romit Bhattacharya; Gabriela Guzman-Martinez; Javier Sanz; Mario J Garcia; Hina W Chaudhry
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

5.  Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes.

Authors:  Shweta Rane; Minzhen He; Danish Sayed; Himanshu Vashistha; Ashwani Malhotra; Junichi Sadoshima; Dorothy E Vatner; Stephen F Vatner; Maha Abdellatif
Journal:  Circ Res       Date:  2009-03-05       Impact factor: 17.367

6.  Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium.

Authors:  Hina W Chaudhry; Nurin H Dashoush; Haiying Tang; Ling Zhang; Xiangyuan Wang; Ed X Wu; Debra J Wolgemuth
Journal:  J Biol Chem       Date:  2004-05-24       Impact factor: 5.157

7.  The hypoxia-inducible microRNA cluster miR-199a∼214 targets myocardial PPARδ and impairs mitochondrial fatty acid oxidation.

Authors:  Hamid el Azzouzi; Stefanos Leptidis; Ellen Dirkx; Joris Hoeks; Bianca van Bree; Karl Brand; Elizabeth A McClellan; Ella Poels; Judith C Sluimer; Maarten M G van den Hoogenhof; Anne-Sophie Armand; Xiaoke Yin; Sarah Langley; Meriem Bourajjaj; Serve Olieslagers; Jaya Krishnan; Marc Vooijs; Hiroki Kurihara; Andrew Stubbs; Yigal M Pinto; Wilhelm Krek; Manuel Mayr; Paula A da Costa Martins; Patrick Schrauwen; Leon J De Windt
Journal:  Cell Metab       Date:  2013-09-03       Impact factor: 27.287

8.  Mammalian heart renewal by pre-existing cardiomyocytes.

Authors:  Samuel E Senyo; Matthew L Steinhauser; Christie L Pizzimenti; Vicky K Yang; Lei Cai; Mei Wang; Ting-Di Wu; Jean-Luc Guerquin-Kern; Claude P Lechene; Richard T Lee
Journal:  Nature       Date:  2012-12-05       Impact factor: 49.962

9.  Mutations in Alström protein impair terminal differentiation of cardiomyocytes.

Authors:  Lincoln T Shenje; Peter Andersen; Marc K Halushka; Cecillia Lui; Laviel Fernandez; Gayle B Collin; Nuria Amat-Alarcon; Wendy Meschino; Ernest Cutz; Kenneth Chang; Raluca Yonescu; Denise A S Batista; Yan Chen; Stephen Chelko; Jane E Crosson; Janet Scheel; Luca Vricella; Brian D Craig; Beth A Marosy; David W Mohr; Kurt N Hetrick; Jane M Romm; Alan F Scott; David Valle; Jürgen K Naggert; Chulan Kwon; Kimberly F Doheny; Daniel P Judge
Journal:  Nat Commun       Date:  2014-03-04       Impact factor: 14.919

10.  MicroRNA Target Identification-Experimental Approaches.

Authors:  Aida Martinez-Sanchez; Chris L Murphy
Journal:  Biology (Basel)       Date:  2013-01-25
View more
  13 in total

Review 1.  Potential clinical benefits of cell therapy in coronary heart disease: an update.

Authors:  Vincenzo Grimaldi; Alberto Zullo; Francesco Donatelli; Francesco Paolo Mancini; Francesco Cacciatore; Claudio Napoli
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 2.  Possible Muscle Repair in the Human Cardiovascular System.

Authors:  Linda Sommese; Alberto Zullo; Concetta Schiano; Francesco P Mancini; Claudio Napoli
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

3.  MicroRNAs regulating meis1 expression and inducing cardiomyocyte proliferation.

Authors:  Raghav Pandey; Yunhan Yang; Laeia Jackson; Rafeeq P H Ahmed
Journal:  Cardiovasc Regen Med       Date:  2016

4.  MicroRNA-1825 induces proliferation of adult cardiomyocytes and promotes cardiac regeneration post ischemic injury.

Authors:  Raghav Pandey; Sebastian Velasquez; Shazia Durrani; Min Jiang; Michelle Neiman; Jeffrey S Crocker; Joshua B Benoit; Jack Rubinstein; Arghya Paul; Rafeeq Ph Ahmed
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

5.  MicroRNA-210-mediated proliferation, survival, and angiogenesis promote cardiac repair post myocardial infarction in rodents.

Authors:  Mohammed Arif; Raghav Pandey; Perwez Alam; Shujia Jiang; Sakthivel Sadayappan; Arghya Paul; Rafeeq P H Ahmed
Journal:  J Mol Med (Berl)       Date:  2017-09-25       Impact factor: 4.599

6.  Caffeic acid ethanolamide prevents cardiac dysfunction through sirtuin dependent cardiac bioenergetics preservation.

Authors:  Shih-Yi Lee; Hui-Chun Ku; Yueh-Hsiung Kuo; Kai-Chien Yang; Ping-Chen Tu; His-Lin Chiu; Ming-Jai Su
Journal:  J Biomed Sci       Date:  2015-09-22       Impact factor: 8.410

Review 7.  New Trends in Heart Regeneration: A Review.

Authors:  Andrei Kochegarov; Larry F Lemanski
Journal:  J Stem Cells Regen Med       Date:  2016-11-29

Review 8.  Non-coding RNA therapeutics for cardiac regeneration.

Authors:  Luca Braga; Hashim Ali; Ilaria Secco; Mauro Giacca
Journal:  Cardiovasc Res       Date:  2021-02-22       Impact factor: 10.787

Review 9.  Regeneration versus scarring in vertebrate appendages and heart.

Authors:  Anna Jaźwińska; Pauline Sallin
Journal:  J Pathol       Date:  2015-10-27       Impact factor: 7.996

10.  miR-199a Overexpression Enhances the Potency of Human Induced-Pluripotent Stem-Cell-Derived Cardiomyocytes for Myocardial Repair.

Authors:  Weihua Bian; Wangping Chen; Thanh Nguyen; Yang Zhou; Jianyi Zhang
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.